每周股票复盘：三星医疗（601567）为巴西南森提供约4407万人民币担保

Core Viewpoint - Samsung Medical (601567) has shown a positive stock performance, with a closing price of 24.95 yuan on January 16, 2026, reflecting a 2.04% increase from the previous week [1] Company Announcements - Samsung Medical provided a performance guarantee for its wholly-owned subsidiary, Brazil Nansen, amounting to approximately 44.07 million yuan, with the guarantee period extended to January 30, 2027 [1] - The guarantee for Brazil Nansen is 33.90 million Brazilian Reais (approximately 44.07 million yuan) and has been approved by the board and shareholders, falling within the previously estimated guarantee limit [1] - Brazil Nansen has a debt-to-asset ratio of 112.50%, and Samsung Medical has actual control over it, indicating that the guarantee risk is manageable [1] - As of the announcement date, the total external guarantees provided by the company amount to 975.35 million yuan, which represents 80.73% of the most recent audited net assets, with no overdue guarantees reported [1]